Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

News from NIAID-Supported Institutions for 2014

Below are links to press releases about NIAID-funded research from some of the institutions we support.

December 2014

Molecules Seen Binding to HIV-1’s Protective Capsule, Blocking Infection
December 30, 2014—The University of Texas Health Science Center at San Antonio

New Treatment Strategy Allows Lower Doses of Toxic Tuberculosis Drug Without Compromising Potency
December 30, 2014—Johns Hopkins University School of Medicine

Artful Imaging Leads to FASEB Honor
December 30, 2014—Albert Einstein College of Medicine

Lyme Disease Enhances Spread of Emerging Tick Infection
December 29, 2014—Yale School of Public Health

Tracing Evolution of Chicken Flu Virus Yields Insight Into Origins of Deadly H7N9 Strain
December 29, 2014— St. Jude Children’s Research Hospital

The Protein GRP78 Identified as a Possible Universal Therapeutic Target for Multiple Viral and Bacterial Infections, Including Ebola, Influenza and Hepatitis and Brain Cancer
December 29, 2014—Virginia Commonwealth University

Enzyme's Alter Ego Helps Activate the Immune System
December 29, 2014—The Johns Hopkins University

Miller School Researchers Receive $5.67 Million Grant for HIV/AIDS Clinical Trials
December 29, 2014—University of Miami Miller School of Medicine

Soligenix Announces Publication of Combination Ricin/Anthrax Vaccine Data
December 29, 2014—Soligenix, Inc.

Team Finds Mechanism of Toxin’s Inflammatory Effect on Lungs
December 29, 2014—The University of Texas Health Science Center at San Antonio

Grant Supports Use of Data Science to Optimize HIV Care
December 23, 2014—Brown University

BioCryst Announces Study Results for BCX4430 in a Non-Human Primate Model of Ebola Virus Infection
December 23, 2014—BioCryst Pharmaceuticals, Inc.

Hearing Loss and HIV
December 26, 2014—San Diego State University

Test Predicts Response to Early Treatment for Dangerous Complication of Stem Cells Transplants Used in Leukemia Patients
December 23, 2014–– Icahn School of Medicine at Mount Sinai

NewLink Genetics, Merck Collaboration to Manufacture Ebola Vaccine Candidate Supported by $30 Million Government Award
December 22, 2014—NewLink Genetics Corporation

New Technique Reveals Immune Cell Motion Through Variety of Tissues
December 18, 2014—Brown University

Building on Big Data, UPenn and UGA Awarded $23.4 Million Pathogen Genomics Database Contract
December 18, 2014—University of Georgia

Scientists Identify New and Beneficial Function of Endogenous Retroviruses in Immune Response
December 18, 2014—UT Southwestern Medical Center

Penn and UGA Awarded $23.4 Million Contract for Pathogen Genomics Database
December 18, 2014—University of Pennsylvania

Pancreatic Islet Cell Transplantation Restores Type 1 Diabetes Patients' Ability to Defend Against Life-Threatening Low Blood Sugar, According to Penn Medicine Study
December 18, 2014—Perelman School of Medicine at the University of Pennsylvania

Study Identifies 53 Approved Drugs that May Block Ebola Infection
December 17, 2014—Icahn School of Medicine at Mount Sinai

Hugs Help Protect Against Stress and Infection, Say Carnegie Mellon Researchers
December 17, 2014—Carnegie Mellon University

Virus Causing Mass Duck Die-Offs on Cape Cod Identified
December 16, 2014—Cornell University

Diatherix Laboratories Receives Second Research Contract from FDA and HHS
December 16, 2014—Diatherix Laboratories

Scientists’ Unique System of Oral Vaccine Delivery to Address Global Health Threats
December 15, 2014—The Forsyth Institute

BioCryst Announces Initiation of a Phase 1 Clinical Trial of BCX4430 for the Treatment of Hemorrhagic Fever Viruses
December 15, 2014—BioCryst Pharmaceuticals, Inc.

Penn Researchers Tame the Inflammatory Response in Kidney Dialysis
December 11, 2014—Perelman School of Medicine at the University of Pennsylvania

 

Cause of Malaria Drug Resistance in SE Asia Identified
December 11, 2014—Columbia University Medical Center

Microbiologists Discover How Gut Bacterial Resources Are Hijacked to Promote Intestinal and Foodborne Illnesses
December 10, 2014—UT Southwestern Medical Center

New Notre Dame-IUSM Study Examines Important Ebola Protein
December 10, 2014—University of Notre Dame

Novel fMRI Technique Identifies HIV-Associated Cognitive Decline Before Symptoms Occur
December 10, 2014—Georgetown University Medical Center

Drug Developed at Pitt Proves Effective Against Antibiotic-Resistant ‘Superbugs’
December 10, 2014—University of Pittsburgh Center for Vaccine Research

Integral Molecular Identifies Potent Inhibitory Antibodies Against Chikungunya Virus
December 10, 2014—Integral Molecular

Immunizing Schoolkids Fights Flu in Others, Too
December 9, 2014—University of Florida

Wayne State University Part of International Collaborative Research Team on Study
December 9, 2014—Wayne State University

Innovative Method for Studying Malaria Parasites Receives 4-Year NIH Grant of Up to $1.8 Million
December 9, 2014—Texas Biomedical Research Institute

Vaccine Holds Hope of Preventing Antibiotic Resistant Skin Infections
December 8, 2014—Los Angeles Biomedical Research Institute

Rapid Ebola Test Is Focus of NIH Grant to Rutgers Scientist
December 8, 2014—Rutgers New Jersey Medical School

National Institutes of Health Renews Funding for VectorBase Program at Notre Dame
December 5, 2014—University of Notre Dame

Research Suggests Ability of HIV to Cause AIDS is Slowing
December 2, 2014—Wellcome Trust

November 2014

Notre Dame Biologist Nora Besansky leads International Consortium in Sequencing the Genomes of Malaria-Carrying Mosquitoes
November 27, 2014—University of Notre Dame

Drugs to Block Angiogenesis Could Provide New Treatment for TB
November 24, 2014—Duke University School of Medicine

Masking HIV Target Cells Prevents Viral Transmission in Animal Model
November 24, 2014—Emory University

Team Reveals Weak Spots in Ebola’s Defenses
November 24, 2014—The Scripps Research Institute

Climate Change Will Slow China's Progress in Reducing Infectious Diseases
November 23, 2014—Emory University

Researchers Tease Out Glitches in Immune System's Self-Recognition
November 21, 2014—The Johns Hopkins University

Halting the Hijacker: Cellular Targets to Thwart Influenza Virus Infection
November 20, 2014—University of Wisconsin-Madison

Breakthrough in Managing Yellow Fever Disease
November 20, 2014—University of California, Riverside

New Study Reveals Why Some People May Be Immune to HIV-1
November 19, 2014—University of Minnesota

UTHealth Awarded $7.3 Million for Health Information Technology Research
November 18, 2014—The University of Texas Health Science Center at Houston

Creating Trust in the Time of Ebola
November 17, 2014—Johns Hopkins Bloomberg School of Public Health

Ferret Genome Holds Clues to Respiratory Diseases
November 17, 2014—University of Washington

BMC Awarded Seven-Year, $21 million NIH Grant to Investigate Tuberculosis, Improve Treatment
November 14, 2014—Boston Medical Center

Scientists Discover New Properties of Microbes That Cause Common Eye Infection
November 12, 2014—Massachusetts Eye and Ear

Semen Directly Impairs Effectiveness of Microbicides that Target HIV
November 12, 2014—Gladstone Institutes

Research Suggests How Mosquitoes Evolved an Attraction to Human Scent
November 12, 2014—The Rockefeller University

Largest Grant Ever Awarded to UW School of Medicine and Public Health Will Continue Inner-City Asthma Research
November 10, 2014—University of Wisconsin

Inhaled Ebola Vaccine May Offer Long-Term Protection from Virus
November 3, 2014—The University of Texas at Austin

New Technique Efficiently Turns Antibodies Into Highly Tuned “Nanobodies”
November 2, 2014—Rockefeller University

October 2014

Immune Cells Proposed as HIV Hideout Don't Last in Primate Model
October 31, 2014—Emory University

Improved Mouse Model Will Accelerate Research on Potential Ebola Vaccines, Treatments
October 31, 2014—University of North Carolina at Chapel Hill

Study: “Wimpy” Antibody Protects Against Kidney Disease in Mice
October 31, 2014—University of Cincinnati

Mouse Model Suggests Varied Genetic Dispositions to Ebola
October 30, 2014—University of Washington

UC Davis Scientists Discover Exact Receptor for DEET That Repels Mosquitoes
October 27, 2014—University of California, Davis

A New Dent in HIV-1's Armor
October 23, 2014—Salk Institute

New Research Offers Hope in Treating Sleeping Sickness
October 23, 2014—Northeastern University

A Real-Time Tracking System Developed to Monitor Dangerous Bacteria Inside the Body
October 22, 2014—Johns Hopkins

If CD8 T Cells Take on One Virus, They’ll Fight Others, Too
October 21, 2014—Brown University

Newly Identified Viral Mutation Could Explain Why Middle-Aged People were More Affected by the 2013-2014 Seasonal Flu
October 21, 2014—Wistar Institute

Divide and Conquer: Novel Trick Helps Rare Pathogen Infect Healthy People
October 17, 2014—University of Birmingham

Scientific Breakthrough Will Help Design the Antibiotics of the Future
October 17, 2014—University of Bristol

Scripps Research Institute Scientists Identify Trigger for Crucial Immune System Cell
October 16, 2014—The Scripps Research Institute

Staph “Gangs” Share Nutrients During Infection
October 16, 2014—Vanderbilt

Study Models Ways to Cut Mexico’s HIV Rates
October 15, 2014—Brown University

NYU Langone Medical Center to Spearhead Multi-Institutional MRSA Research Funded by the National Institutes of Health
October 15, 2014—NYU Langone Medical Center

Scripps Research Institute Team Receives $6.6 Million to Investigate Deadly Lassa Virus
October 14, 2014—The Scripps Research Institute

SomaLogic Announces Agreement to Deploy SOMAscan Assay at NIH Center
October 13,2014—SomaLogic, Inc.

Study Reveals How Deadly MERS Virus Enters Human Cells
October 13, 2014—Cornell University

Single Gene Links Susceptibility to Rare Infections with Predisposition to Autoimmune Disease
October 12, 2014—Rockefeller University

Antiretroviral Therapy Benefits HIV-infected Stimulant Users, UCSF Study Shows
October 10, 2014—University of California - San Francisco

Promising Early Success and Safety Results From International Gene Therapy Trial for 'Bubble Boy' Disease Reported in New England Journal of Medicine
October 9, 2014—Dana-Farber/Boston Children's Cancer and Blood Disorders Center

School of Medicine Begins Ebola Vaccine Trials
October 9, 2014—University of Maryland School of Medicine (UM SOM)

UAB Part of NIH-Funded Research Consortia Studying More Than 200 Rare Diseases
October 9, 2014—University of Alabama at Birmingham

University of Maryland School of Medicine and Malian Ministry of Health begin Human Trials of Experimental Ebola Vaccine in Mali, West Africa
October 9, 2014—University of Maryland School of Medicine

Effective Treatments Available for HIV Patients Not Eligible for Efavirenz Regimens
October 6, 2014—Emory University

Scientists Discover Pain Receptor on T-Cells
October 5, 2014—University of California, San Diego School of Medicine

Gut Bacteria Are Protected by Host During Illness
October 2, 2014—University of Chicago

September 2014

UCI Study Uncovers Important Process for Immune System Development
September 30, 2014—UC Irvine

Surprising Diversity of Antibody Family Provides Clues for HIV Vaccine Design
September 29, 2014—The Scripps Research Institute

Carnegie Mellon Research Shows Viral DNA Infects Cells by Changing from Solid to Fluid-Like State
September 29, 2014—Carnegie Mellon University

Yerkes Researchers First to Show Irradiation Plus Transplantation Effective For Treating HIV/AIDS
September 29, 2014—Emory University

Geisel Researchers Contribute to Study of Trained Immunity
September 26, 2014—Geisel School of Medicine at Dartmouth

Dry Roasting Could Help Trigger Peanut Allergy
September 22, 2014—Oxford University

Penn Researchers Describe New Cancer Drug Target Involving Lipid Chemical Messengers
September 19, 2014—Perelman School of Medicine, University of Pennsylvania

Research Predicts Possible 6,800 New Ebola Cases This Month
September 19, 2014—Arizona State University

Soligenix Awarded NIAID Contract Valued up to $24.7 Million for the Development of Heat Stable RiVax™ Vaccine
September 19, 2014—Soligenix, Inc.

New Insights on an Ancient Plague Could Improve Treatments for Infections
September 18, 2014—Duke Medicine

Research Yields a Game Changer for Improving Understanding of Ebola and Great Apes
September 18, 2014—The Wildlife Conservation Society

A New Way to Prevent the Spread of Devastating Diseases
September 18, 2014—Caltech

BioCryst Receives Additional NIAID Funding for Manufacture and Development of BCX4430 to Treat Hemorrhagic Virus Diseases
September 18, 2014—BioCryst Pharmaceuticals, Inc.

Point-of-Care CD4 Testing is economically Feasible for HIV Care in Resource-Limited Areas
September 16, 2014—Massachusetts General Hospital

ContraFect Corporation's Universal Influenza Treatment Receives SBIR Funding
September 16, 2014—ContraFect Corporation

Professor Dennis Burton: In Search of an Effective HIV/AIDS Vaccine
September 15, 2014—The Scripps Research Institute

New Insights in Survival Strategies of Bacteria
September 14, 2014—VIB (the Flanders Institute for Biotechnology)

Geneva & Partners in Development of Ebola Drug
September 12, 2014—The Geneva Foundation

Intestinal Bacteria Needed for Strong Flu Vaccine Responses in Mice
September 11, 2014—Emory University

PharmAthene Awarded Contract of Up to $28.1 Million to Develop Next Generation Thermostable Anthrax Vaccine
September 10, 2014—PharmAthene, Inc.

Study Sheds Light on Asthma and Respiratory Viruses
September 9, 2014—Washington University School of Medicine in St. Louis

Unusual Immune Cell Needed to Prevent Oral Thrush, Pitt Researchers Find
September 8, 2014—University of Pittsburgh School of Medicine

Suppressing Food Allergies Quickly Is the Goal of UC Research Team
September 8, 2014—University of Cincinnati College of Medicine

Emergent BioSolutions Awarded Contract to Develop a Dry Formulation of NuThrax, a Next Generation Anthrax Vaccine
September 8, 2014—Emergent BioSolutions Inc.

Team Identifies Important Regulators of Immune Cell Response
September 8, 2014—The Scripps Research Institute

MCW Scientists to Investigate New Therapy for Obstructive Lung Disease
September 4, 2014—The Medical College of Wisconsin

Avian Influenza Virus Isolated in Harbor Seals Poses a Threat to Humans
September 4, 2014—St. Jude Children’s Research Hospital

Johnson & Johnson Responds to Ebola Crisis with Commitment to Accelerate Vaccine Program in Collaboration with the US National Institutes of Health (NIH) and Provide Humanitarian Relief Aid
September 4, 2014—Johnson & Johnson

Bavarian Nordic Accelerates Ebola Vaccine Development Programs in Collaboration with the U.S. National Institutes of Health
September 4, 2014—Bavarian Nordic

Leaky Gut—A Source of Non-AIDS Complications in HIV-Positive Patients
September 3, 2014—Case Western Reserve University School of Medicine

Soligenix Announces Positive Survival Results with Heat Stable Ricin Toxin Vaccine
September 2, 2014—Soligenix, Inc.

Biochemists Find New Treatment Options for Staph Infections, Inflammatory Diseases
September 2, 2014—Kansas State University

War Between Bacteria and Phages Benefits Humans
September 2, 2014—Tufts University

August 2014

Discovery Reveals how Bacteria Distinguish Harmful Versus Helpful Viruses
August 31, 2014—The Rockefeller University

Sensory-Tested Drug-Delivery Vehicle Could Limit Spread of HIV, AIDS
August 28, 2014—Penn State

Drug Shows Promise Against Sudan Strain of Ebola in Mice
August 28, 2014—Albert Einstein College of Medicine

Synthesis Produces New Antibiotic
August 28, 2014—Rice University

Malaria’s Clinical Symptoms Fade on Repeat Infections Due to Loss of Immune Cells, UCSF-Led Team Finds
August 27, 2014—UC San Francisco

Key to Universal Flu Vaccine: Embrace the Unfamiliar
August 27, 2014—Emory Vaccine Center

Holding On: Bond LSC Scientist Discovers Protein Prevents Release of HIV and Other Viruses From Infected Cells
August 26, 2014—University of Missouri

Ebola Vaccine Using Immunovaccine’s DepoVax Proves Highly Efficacious in Non-Human Primate Study
August 25, 2014—Immunovaccine Inc.

UAB Researcher Granted $1 Million to Study Deadly Bacteria Passed to Babies from 25 Percent of Mothers
August 22, 2014—University of Alabama at Birmingham

Fungus Deadly to AIDS Patients Found to Grow on Trees
August 21, 2014—Duke University School of Medicine

Some Anti-Inflammatory Drugs Affect More Than Their Targets
August 21, 2014—Johns Hopkins University School of Medicine

Study Identifies Protein that Helps Prevent Active Tuberculosis in Infected Patients
August 20, 2014—UCLA

Houston Methodist Researchers Using NIH Grant to Examine Molecular Basis of Transplant Rejection
August 19, 2014—Houston Methodist Research Institute

New Vaccine Shows Promise as Stronger Weapon Against Both Tuberculosis and Leprosy
August 19, 2014—UCLA

Worm Virus Details Come to Light
August 18, 2014—Rice University

Food Allergies More Widespread Among Inner-City Children
August 14, 2014—Johns Hopkins Medicine

Gut Flora Influences HIV Immune Response
August 13, 2014—Duke Medicine

OMRF Receives $14.5 Million Grant to Continue Anthrax Studies
August 13, 2014—Oklahoma Medical Research Foundation

BioCryst Receives Additional NIAID Funding to Advance Development of BCX4430 to Treat Hemorrhagic Fever Virus Diseases
August 13, 2014—BioCryst Pharmaceuticals, Inc

NIH Awards Sedia Biosciences $195,490 SBIR Grant for Rapid HIV-1 Incidence Assay
August 18, 2014—Sedia Biosciences Corporation

Developing A Better Test For Lyme Disease Diagnosis
August 6, 2014—RareCyte, Inc.

Toward Personalized Medicine for Kidney Transplant Recipients
August 4, 2014—UC San Francisco

July 2014

Molecule Enhances Copper’s Lethal Punch Against Microbes
July 31, 2014—Duke University

Researchers Uncover Clues to Flu’s Mechanisms
July 31, 2014—Rice University

Transplantation Shown to Be Highly Effective in Treating Immune Deficiency in Children
July 30, 2014—Memorial Sloan Kettering

Mechanism Found for Development of Protective HIV Antibodies
July 24, 2014—Duke Medicine

GW Researcher Unlocks Next Step in Creating HIV-1 Immunotherapy Using Fossil Virus
July 17, 2014—George Washington University

TGen-Led International Study Finds Likely Origin of Virulent Lung Fungus Invading Pacific Northwest
July 15, 2014—Translational Genomics Research Institute

"Viral Fitness" Discovery Defines HIV Vulnerability
July 11, 2014—Emory University Health Sciences

Bacterial Respiratory Tract Colonization Prior to Catching the Flu May Protect Against Severe Illness
July 10, 2014—The Wistar Institute

Study Points To Potential New Target For Antibiotics Against E. coli, Other Bugs
July 10, 2014—The Ohio State University

Control Strategy for Dengue, Malaria Increases Risk of West Nile Virus
July 10, 2014—Penn State

Recalled Yogurt Contained Highly Pathogenic Mold
July 8, 2014—Duke University

La Jolla Institute Develops New Approach to Identify Genes Poised to Respond in Asthma Patients
July 8, 2014—La Jolla Institute

Shields Up! Research Reveals New, Protective Role for Specialized Cells in Intestinal and Respiratory Systems
July 7, 2014—University of California, Riverside

NYU Researchers Tackle Racial/Ethnic Disparities in HIV Medical Studies
July 7, 2014—New York University College of Nursing

Researchers Learn How Beryllium Causes Deadly Lung Disease
July 3, 2014—National Jewish Health

Screening Children for Celiac Disease
July 3 2014—University of Colorado School of Medicine

Institute for Genome Sciences Awarded NIAID Grant
July 1, 2014—University of Maryland School of Medicine

Sorrento Awarded up to $2.6 Million from the National Institutes of Health (NIH) for the Development of New Anti-bacterial Bispecific Antibodies and Antibody Formulated Drug Conjugates
July 1, 2014—Sorrento Therapeutics, Inc.

June 2014

USAMRIID Research Sheds Light on How Deadly Lassa Virus Infects Cells
June 27, 2014—USAMRIID

Corgenix, Research Group Announce NIH Grant to Advance Work on Ebola Rapid Diagnostic Test Kit
June 26, 2014—Corgenix Medical Corporation

Fighting Parasitic Infection Inadvertently Unleashes Dormant Virus
June 26, 2014—Washington University School of Medicine in St. Louis

Salmonella's Achilles' Heel: Reliance on Single Food Source to Stay Potent
June 26, 2014—The Ohio State University

New Infections Cause Dormant Viruses to Reactivate
June 26, 2014—University of Florida

ASPIRE Phase III Trial of a Vaginal Ring for HIV Prevention Completes Enrollment of 2,629 Women
June 26, 2014—Microbicide Trials Network

Researchers One Step Closer to Countering Deadly Nipah Virus
June 25, 2014—University of Texas Medical Branch at Galveston

Sequencing Efforts Miss DNA Crucial to Bacteria’s Disease Causing Power
June 25, 2014—Rockefeller University

Lowering Toxicity of New HIV Drugs Predicted to Improve Life Expectancy
June 25, 2014—University of Pittsburgh Graduate School of Public Health

UF Part of Research Team that Finds Equine Influenza Virus in Camels
June 24, 2014—University of Florida

TSRL Announces Receipt of $4.2 Million in New SBIR Funding
June 24, 2014—Therapeutic Systems Research Laboratories, Inc.

Cellceuti x Anti-Fungal Compounds Awarded $1.5 Million SBIR Grant
June 23, 2014—Cellceutix Corporation

New Monkey Model for AIDS Offers Promise for Medical Research
June 19, 2014—The Rockefeller University

Antibiotic Developed 50 Years Ago May Be the Key to Fighting ‘Superbugs’
June 18, 2014—University at Buffalo

New Stanford Blood Test Identifies Heart-Transplant Rejection Earlier Than Biopsy Can
June 18, 2014—Stanford University

Researchers Map Gene Differences in Yellow Fever, Malaria Mosquitoes, to Help Prevent Disease
June 17, 2014—Virginia Tech

Cellular Force that Drives Allergy and Asthma Can Be Blocked by Interferon, Immunologists Find
June 16, 2014—UT Southwestern Medical Center

Study Shows Chikungunya Virus Mutation Places Several Countries at Risk of Epidemic Circulation
June 16, 2014—University of Texas Medical Branch at Galveston

Burst of Mutations During Initial Infection Allows Bacteria To Evade Human Immune Response
June 13, 2014—Penn State

Genetic Barcode for Malaria Could Help Contain Outbreaks
June 13, 2014—London School of Hygiene & Tropical Medicine

Grant to Entomologist Will Advance Research on African Malaria Mosquito
June 12, 2014—University of California, Riverside

Viral Infections, Including Flu, Could Be Inhibited by Naturally Occurring Protein, UPCI Finds
June 12, 2014—University of Pittsburgh Cancer Institute

Dormant Viruses Re-Emerge in Patients with Lingering Sepsis, Signaling Immune Suppression
June 11, 2014—Washington University School of Medicine in St. Louis

Study Finds How Protein Blocks HIV Life Cycle in Elite Controllers
June 11, 2014—Massachusetts General Hospital (MGH)

TB Dogma Upended: Even Uninfected Cells Trigger Immune Defenses
June 11, 2014—NYU Langone Medical Center

Genes Found in Nature Yield 1918-Like Virus with Pandemic Potential
June 11, 2014—University of Wisconsin-Madison

A Key Step Toward a Safer Strep Vaccine
June 11, 2014—University of California, San Diego School of Medicine

Gum Disease Bacteria Selectively Disarm Immune System, Penn Study Finds
June 11, 2014—University of Pennsylvania

Infant Immune Systems Learn Fast, but Have Short Memories
June 11, 2014—Cornell University

Herpes Infected Humans Before They Were Human
June 10, 2014—University of California, San Diego School of Medicine

Finding Could Lead to New Strategies for Malaria Control
June 6, 2014—Harvard School of Public Health

HIV Transmission Networks Mapped to Reduce Infection Rate
June 5, 2014—University of California, San Diego School of Medicine

Researchers at the Gladstone Institutes Find Novel Approach to Reactivate Latent HIV
June 5, 2014—Gladstone Institutes

J. Craig Venter Institute Awarded 5 Year, Approximately $25 Million NIH Grant to Establish a Genome Center for Infectious Diseases
June 5, 2014—J. Craig Venter Institute

UGA Researchers Receive $1.8 Million Grant to Fight Deadly Parasite
June 4, 2014—University of Georgia

Scripps Research Institute Study: Hemorrhagic Fevers Can Be Caused by Body’s Antiviral Interferon Response
June 4, 2014—The Scripps Research Institute

What Makes a Virus Infectious? Researcher to Study the Conversion from Harmless Viral Particles to Disease-Causing Viruses
June 3, 2014—Medical College of Wisconsin

Hemispherx Announces that the University of Texas Medical Branch Confirms Activity of Alferon® N Against MERS (Middle East Respiratory Syndrome) Virus
June 3, 2014—Hemispherx Biopharma

Purdue Researchers Shut Down a SARS Cloaking System; Findings Could Pave the Way to Vaccines for SARS Virus, MERS
June 3, 2014—Purdue University

May 2014

Scripps Research Institute Scientists Win $13 Million Grant in AIDS Vaccine Effort
May 29, 2014—The Scripps Research Institute

Penn Medicine Program Receives $10 Million Renewal for Studying the Oldest Branch of the Immune System
May 29, 2014—University of Pennsylvania Perelman School of Medicine

UNL Team Awarded $1.9M to Develop New Approach to HIV Vaccine
May 29, 2014—University of Nebraska-Lincoln

Infant Immunity, Though Fleeting, Found to Be Strong
May 27, 2014—Cornell

Stanford Researchers Discover Immune System's Rules of Engagement
May 22, 2014—Stanford School of Medicine

Bacterial Adaptation Contributes to Pneumococcal Threat in Sickle Cell Disease Patients
May 22, 2014—St. Jude Children’s Research Hospital

InDevR to Develop Automated Hemagglutination Analyzer
May 20, 2014—InDevR

Scientists Develop New Approach for Sampling Gut Bacteria
May 19, 2014—The Forsyth Institute

Painkillers May Decrease Susceptibility to Recurring Urinary Infections
May 18, 2014—Washington University School of Medicine

Breakthrough in HIV/AIDS Research Gives Hope for Improved Drug Therapy
May 16, 2014—University of Pittsburgh Center for Vaccine Research

"Bystander" Chronic Infections Thwart Development of Immune Cell Memory, Penn Study Finds
May 15, 2014—University of Pennsylvania Perelman School of Medicine

Penn Vet Study Reveals Salmonella’s Hideout Strategy
May 15, 2014— University of Pennsylvania School of Veterinary Medicine

TB Lung Infection Causes Changes in the Diversity of Gut Bacteria in Mice
May 13, 2014—Johns Hopkins

Birth by C-Section, Early Antibiotic Use Put Kids at Risk for Allergic Esophagitis
May 12, 2014—Johns Hopkins Children’s Center

Carbohydrates Direct Immunity Against Camouflaged Bacteria
May 12, 2014—Emory University School of Medicine

New Cancer Immunotherapy Aims Powerful T Cells Against Tumors
May 12, 2014—UC San Francisco

$32 Million NIH Grant Funds Study of Multipurpose Infection Fighter
May 8, 2014—Washington University School of Medicine

UTMB Awarded $4.4M to Develop Universal Flu Vaccine
May 7, 2014—University of Texas Medical Branch

Immune Cells Outsmart Bacterial Infection by Dying, Penn Vet Study Shows
May 5, 2014—University of Pennsylvania School of Veterinary Medicine

Drinking, Even Casual Amounts, Poses Much Greater Risk for Advanced Liver Disease in HIV/Hepatitis C Patients
May 2, 2014—Penn Medicine

Penn Vet Research Identifies Compounds That Control Hemorrhagic Viruses
May 1, 2014—University of Pennsylvania School of Veterinary Medicine

April 2014

Autoimmune Diseases May Succumb to New Drug Strategy
April 30, 2014—UC San Francisco

New Experimental Vaccine Produces Immune Response Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
April 30, 2014—University of Maryland School of Medicine

Live Virus Implicates Camels in MERS Outbreak
April 29, 2014—Columbia University Mailman School of Public Health

Low Cholesterol in Immune Cells Tied to Slow Progression of HIV
April 29, 2014—University of Pittsburgh Graduate School of Public Health

A Drug that Packs a Punch: New Compound Works Better Against Resistant HIV
Apr 28, 2014—University of Missouri

Team Finds New Point of Attack on HIV for Vaccine Development
April 28, 2014—The Scripps Research Institute

Discovery Could Lead to Prevention and Treatment of Middle East Respiratory Syndrome
April 28, 2014—Dana-Farber Cancer Institute

Rutgers Gets up to $26 Million Grant to Lead Development of New Antibiotics
April 25, 2014—Rutgers

Use of Frozen Material for Fecal Transplant Successful in Treating C. difficile Infection
April 24, 2014—Massachusetts General Hospital

Using New Single-Cell Technologies, Researchers Create Comprehensive Map of Human B Cell Development
April 24, 2014—Columbia University

Re-Emergence of Ebola Focuses Need for Global Surveillance Strategies
April 17, 2014—EcoHealth Alliance

Novel Stapled Peptide Nanoparticle Combination Prevents RSV Infection, Study Finds
April, 17, 2014—University of South Florida

Multitarget TB Drug Could Treat Other Diseases, Evade Resistance
April, 17, 2014—University of Illinois

Deadly Human Pathogen Cryptococcus Fully Sequenced
April 17, 2014—Duke University

Progress in Understanding Immune Response in Severe Schistosomiasis
April 16, 2014— Tufts University

HIV+ Women Respond Well to HPV Vaccine
April 16, 2014— Brown University

Scientists Unlock Secrets of Protein Produced by Disease-Causing Fungus
April 16, 2014—The University of Texas Health Science Center at San Antonio

New MRSA Superbug Emerges in Brazil
April 16, 2014—The University of Texas Health Science Center at Houston

Some Immune Cells Defend Only One Organ
April 16, 2014—Washington University School of Medicine in St. Louis

Researchers Have Developed New Antiviral Drug to Combat Measles Outbreaks
April 16, 2014—Georgia State University

Progress in Understanding Immune Response in Severe Schistosomiasis
April 16, 2014—Tufts University

NYU Researchers Find Computerized Counseling Reduces HIV-1 Viral Load and Sexual Transmission Risk
April 15, 2014—New York University

Community-Based HIV Prevention Can Boost Testing, Help Reduce New Infections
April 15, 2014—UCLA

LA BioMed to Study Passive Vaccination Against a Deadly Hospital-Acquired Infection NIH Grant Funds Research into New Approach for Combating Acinetobacter Infections
April 10, 2014—LA BioMed

Mechanical Forces Affect T-Cell Recognition and Signaling, Researchers Show
April 10, 2014—Georgia Tech

HIV Battle Must Focus on Hard-Hit Streets
April 10, 2014—Brown University

Enzyme Revealed as Promising Target to Treat Asthma and Cancer
April 10, 2014—Johns Hopkins

Researchers Discover Possible New Target to Attack Flu Virus
April 9, 2014—The University of Texas at Austin

Rapid, Broad Countermeasures Sought Against Mystery Infections
April 8, 2014—University of Washington

Targeting Sperm Protection in Mosquitoes Could Help Combat Malaria
April 8, 2014—Imperial College London

Disruption of VISTA Plays an Important Role in Regulating Immune Response
April 7, 2014—Geisel School of Medicine at Dartmouth

Sanaria PfSPZ Malaria Vaccine Wins 2014 Vaccine Industry Excellence Award for “Best Prophylactic Vaccine”
April 7, 2014—Sanaria Inc.

Scientists Generate 3D Structure for the Malaria Parasite Genome
April 4, 2014—University of California, Riverside

Immunovaccine and Pfenex Report Positive Results From Single Dose Anthrax Vaccine Studies
April 1, 2014—Immunovaccine Inc.

Corgenix, Tulane and Viral Hemorrhagic Fever Consortium Publish Promising Results from Lassa Fever Trial
April 1, 2014—Corgenix

March 2014

Air Pollution from Traffic Increases Odds of Hospital Readmission for Asthma
March 27, 2014—Cincinnati Children’s Hospital Medical Center

Using Tobacco to Thwart West Nile Virus
March 27, 2014—Arizona State University

Scripps Florida Scientist Awarded $2.3 Million to Study Dengue Fever and Related Viruses
March 27, 2014—The Scripps Research Institute

Penn Dental Medicine-NIH Team Reverses Bone Loss in Immune Disorder
March 26, 2014—University of Pennsylvania School of Dental Medicine

A Way to End Recurrent Urinary Tract Infections? Study Gives Hope
March 25, 2014—University of Utah

New Childhood Tuberculosis Estimates Double the Number Previously Thought
March 24, 2014—Brigham and Women's Hospital

Drugs Fail to Reawaken Dormant HIV Infection
March 24, 2014—Johns Hopkins Medicine

Researchers at LSTM Unlock the Secret of Multiple Insecticide Resistance in Mosquitoes
March 21, 2014—Liverpool School of Tropical Medicine

Multimillion-Dollar Antiviral Drug Discovery Center Aims to Take on Diseases like West Nile, Influenza
March 20, 2014—University of Alabama at Birmingham

Consortium Wins Up to $28 Million to Find Best Ebola Treatment
March 20, 2014—The Scripps Research Institute

Past HIV Vaccine Trials Reveal New Path to Success
March 19, 2014—Duke Medicine

Scientist Receives NIH Grant to Find Cure for Infectious Disease
March 19, 2014—Clemson University

Stopping Malaria Transmission: A Virginia Tech Biochemist is Out For Blood
March 19, 2014—Virginia Tech

One in Three Patients with Bloodstream Infections Given Inappropriate Therapy
March 18, 2014—Duke Medicine

Nasty Nanoinjectors Pose a New Target for Antibiotic Research
March 13, 2014—University of Kansas

Unique Individual Demonstrates Desired Immune Response to HIV Virus
March 12, 2014—Duke Medicine

Seattle BioMed Awarded $9.8 Million Grant from the National Institutes of Health to Develop Vaccine Against HIV/AIDS
March 10, 2014—Seattle BioMed

Center for Infection and Immunity’s W. Ian Lipkin Receives NIH Grant of up to $31 Million to Establish New Center for Excellence for Translational Research
March 10, 2014—Columbia University Mailman School of Public Health

Notre Dame Chemists Discover New Class of Antibiotics
March 6, 2014—University of Notre Dame

Personalized Gene Therapy Locks Out HIV, Paving the Way to Control Virus Without Antiretroviral Drugs
March 5, 2014—University of Pennsylvania

UTMB to Collaborate on Program Targeting Potential Bioterrorist Pathogens Ebola and Marburg
March 4, 2014—University of Texas Medical Branch at Galveston

Argos Therapeutics Presents New Data From Clinical Research for AGS-004 Patient-Specific Immunotherapy in Treatment of HIV
March 4, 2014—Argos Therapeutics Inc.

In First Moments of Infection, a Division and a Decision
March 4, 2014—University of California, San Diego School of Medicine

Novel Drug Treatment Protects Primates from Deadly Marburg Virus
March 3, 2014—U.S. Army Medical Research Institute of Infectious Diseases

BioCryst Announces Nature Publication Demonstrating Efficacy of BCX4430 in a Non-Human Primate Model of Filovirus Infection
March 3, 2014—BioCryst Pharmaceuticals, Inc.

February 2014

Combination Therapies Combat HIV at Cell Junctions, Yale Researchers Find
February 28, 2014—Yale University

Light Zaps Viruses: How Photosensitization Can Stop Viruses from Infecting Cells
February 28, 2014—UCLA AIDS Institute

Scripps Research Institute Scientists Describe Deadly Immune ‘Storm’ Caused by Emergent Flu Infections
February 27, 2014—The Scripps Research Institute

Mayo Clinic Discovers African-Americans Respond Better to Rubella Vaccine
February 26, 2014—Mayo Clinic

UNC Researchers Discover New Target for Dengue Virus Vaccine
February 26, 2014—University of North Carolina

Vitamin A May Help Boost Immune System to Fight Tuberculosis
February 25, 2014—UCLA

Taming Microbes to Combat Antibiotic Resistance NIH Grant to LA BioMed Researchers Funds New Approach to Treat MRSA
February 25, 2014—Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center

Northwestern Medicine Awarded More Than $8.4 Million for Chronic Rhinosinusitis Research
February 25, 2014—Northwestern Memorial Hospital

Bavarian Nordic’s MVA-BN® Vaccine Platform Selected by U.S. Department of Defense for New Vaccine Development
February 21, 2014—Bavarian Nordic

The Parasite that Escaped Out of Africa: Origin of Deadly Human Malaria Parasite Linked to Primates in Africa, not Asia, as Once Thought, According to Penn-Led Study
February 21, 2014—University of Pennsylvania Perelman School of Medicine

Team Uncovers Drug Resistance Mechanism that Could Impact Development of Two Antibiotic Drugs
February 20, 2014—The Scripps Research Institute

Essential Protein Discovered for Malaria Parasite's Transmission to Mosquitos
February 20, 2014—Penn State

Rutgers Scientists Identify Structure of Virus that Could Lead to Hepatitis C Vaccine
February 19, 2014—Rutgers University

The Nose Knows in Asthma
February 19, 2014—National Jewish Health

Polyplus-transfection and the National Institute of Health Sign a Research License Agreement for PEI-Based Transfection Technologies
February 17, 2014—Polyplus-transfection SA

Of Mice and Men: Fine-Tuning Salmonella-Based Vaccines
February 17, 2014—Arizona State University

Environment Influences Ability of Bacterium to Block Malaria Transmission
February 17, 2014—Penn State

Soligenix Announces $300,000 NIAID SBIR Grant Award Supporting Further Evaluation of SGX943 as a Treatment for Melioidosis
February 14, 2014—Soligenix, Inc.

Researchers Find Source of New Lineage of Immune Cells
February 14, 2014—University of Chicago

UA Study on Flu Evolution May Change Textbooks, History Books
February 14, 2014—University of Arizona

Popular Disinfectants Do Not Kill HPV
February 12, 2014—Penn State

Field Trials Show New Technology Able To Prevent Lyme Disease Transmission
February 12, 2014—US BIOLOGIC

Chips that Listen to Bacteria
February 11, 2014—Columbia University School of Engineering and Applied Science

Researchers Discover Immune Signature that Predicts Poor Outcome in Influenza Patients
February 10, 2014—St. Jude Children’s Research Hospital

Newly Found Tactics in Offense-Defense Struggle with Hepatitis C Virus
February 10, 2014—University of Washington

Caltech-Developed Method for Delivering HIV-Fighting Antibodies Proven Even More Promising
February 9, 2014—California Institute of Technology

New Investigational Drug Holds Promise for Combatting Deadly Mucormycosis Infections
February 6, 2014—Los Angeles Biomedical Research Institute

UC Irvine Salmonella Study has Surprising Results
February 6, 2014—University of California, Irvine

Quick Test Finds Signs of Diarrheal Disease
February 6, 2014—Rice University

Powerful Bacterial Immune Response Defined by New Study
February 6, 2014—University of California, Davis

The Ultimate Decoy: Scripps Research Institute Scientists Find Protein that Helps Bacteria Misdirect Immune System
February 6, 2014—The Scripps Research Institute

Decoding Dengue and West Nile
February 6, 2014—University of Michigan

Scripps Research Institute Scientists Create Potential Vaccine Ingredient for Childhood Respiratory Disease
February 5, 2014—The Scripps Research Institute

Immune Cells Need a Second Opinion
February 4, 2014—University of Bonn Medical Center

Bacterial Fibers Critical to Human, Avian Infection
February 4, 2014—Biodesign Institute at Arizona State University

HIV-Infected Teens Delaying Treatment Until Advanced Disease, Johns Hopkins Study Shows
February 3, 2014—Johns Hopkins

Mosquito Sperm Have a Sense of Smell
February 3, 2014—Vanderbilt University

U.S. National Institutes of Health to Commence New Study of Pluristem’s PLX Cells for Acute Radiation Syndrome Treatment
February 3, 2014—Pluristem Therapeutics, Inc.

January 2014

DNA of Peanut-Allergic Kids Changes with Immune Therapy, Study Finds
January 31, 2014—Stanford University School of Medicine

U.Va., Russian Researchers Target Drug-Resistant TB
January 31, 2014—University of Virginia School of Medicine

A Detailed Look at HIV in Action
January 30, 2014—California Institute of Technology

Trick that Aids Viral Infection is Identified
January 30, 2014—Washington University School of Medicine in St. Louis

Findings Point to Potential Treatment for virus Causing Childhood Illnesses
January 29, 2014—Purdue University

Research Uncovers Historical Rise, Fall and Re-Emergence of Plague Strains
January 27, 2014—Northern Arizona University

Promising Class of Antibiotics Discovered for Treatment of Drug-Resistant Tuberculosis
January 27, 2014—St. Jude Children’s Research Hospital

Team to Study Control of Malaria-Related Parasite Growth with $2.1 Million NIH Grant
January 22, 2014—University of South Florida

Vivaldi Biosciences Signs Cooperative Research and Development Agreement (CRADA) with National Institute of Allergy and Infectious Diseases (NIAID) to Develop Live Attenuated Influenza Vaccine Against Influenza H7N9
January 21, 2014—Vivaldi Biosciences Inc.

NYBC Viral Immunology Lab Receives NIH Support to Develop MERS Vaccine
January 20, 2014—New York Blood Center

Decoded: DNA of Blood-Sucking Worm that Infects World’s Poor
January 19, 2014—Washington University School of Medicine in St. Louis

Soligenix Announces Positive One-Year High-Temperature Stability Results with ThermoVax™ Vaccine Heat Stabilization Technology
January 15, 2014—Soligenix, Inc.

Engineering Professor Co-Authors Nature Medicine Paper on HIV
January 13, 2014—University of Delaware

Wistar to Launch Largest Randomized Trial Aiming for an HIV Cure by Diminishing Viral Reservoir Beyond Current Therapies
January 13, 2014— The Wistar Institute

Enanta Pharmaceuticals Initiates Phase 1 Study of MRSA Infection Candidate EDP-788
January 13, 2014—Enanta Pharmaceuticals, Inc.

MGH/Ragon Institute Study Identifies Population of Stem-Like Cells Where HIV Persists in Spite of Treatment
January 13, 2014—Massachusetts General Hospital

Knopp Biosciences And NIH to Collaborate in Evaluating Dexpramipexole in Patients with Hypereosinophilic Syndrome
January 8, 2014—Knopp Biosciences LLC

Scripps Florida Scientists Identify Possible Key to Drug Resistance in Crohn’s Disease
January 8, 2014—The Scripps Research Institute

On-Demand Vaccines Possible with Engineered Nanoparticles
January 7, 2014—University of Washington

Finding About Classic Suppressor of Immunity Points Toward New Therapies for Bad Infections
January 7, 2014—Georgia Regents University

Draper Nanotechnology Could Fight Influenza, Other Viruses
January 6, 2014—Draper Laboratory

back to top

Archives
2011
2012
2013
2015

​​
 

Last Updated May 11, 2015